Tomoki Yamatsuji Selected Research

Antigens

12/2011

A phase I study of vaccination with NY-ESO-1f peptide mixed with Picibanil OK-432 and Montanide ISA-51 in patients with cancers expressing the NY-ESO-1 antigen.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tomoki Yamatsuji Research Topics

Disease

39	Neoplasms (Cancer) 07/2021 - 09/2003
15	Esophageal Neoplasms (Esophageal Cancer) 03/2013 - 10/2004
9	Neoplasm Metastasis (Metastasis) 05/2021 - 10/2004
6	Stomach Neoplasms (Stomach Cancer) 01/2022 - 09/2003
6	Carcinoma (Carcinomatosis) 07/2010 - 01/2004
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2016 - 07/2011
4	Lung Neoplasms (Lung Cancer) 07/2015 - 11/2010
3	Lymphatic Metastasis 05/2021 - 10/2004
3	Hyperglycemia 01/2021 - 04/2007
3	Carcinogenesis 10/2010 - 01/2010
3	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 11/2009 - 09/2005
2	Colorectal Neoplasms (Colorectal Cancer) 01/2016 - 07/2012
2	Renal Cell Carcinoma (Grawitz Tumor) 03/2013 - 07/2011
2	Colonic Neoplasms (Colon Cancer) 07/2012 - 09/2003
1	Residual Neoplasm 01/2022
1	Lymphoma (Lymphomas) 08/2021
1	Cecal Neoplasms 07/2021
1	Ileus 07/2021
1	Pathologic Constriction (Stenosis) 05/2021
1	Pancreatitis 01/2021
1	Sigmoid Neoplasms 01/2021
1	Dyslipidemias (Dyslipidemia) 01/2021
1	Hypertriglyceridemia 01/2021
1	Margins of Excision 10/2020
1	Malignant Mesothelioma 01/2020
1	Retroperitoneal liposarcoma 01/2019
1	Esophageal Squamous Cell Carcinoma 11/2017
1	Mycoses (Diseases, Fungus) 09/2013
1	Hypoxia (Hypoxemia) 03/2013
1	Weight Loss (Weight Reduction) 12/2012
1	Gastroesophageal Reflux (GERD) 12/2012
1	Injection Site Reaction 12/2011
1	Fever (Fevers) 12/2011
1	Melena 02/2011
1	Leiomyoma (Uterine Fibroids) 01/2011

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2013 - 01/2004
7	heparanaseIBA 07/2010 - 10/2004
5	Focal Adhesion Protein-Tyrosine KinasesIBA 07/2012 - 07/2008
4	TAE226IBA 07/2012 - 07/2008
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 07/2010 - 11/2005
2	AcidsIBA 08/2021 - 11/2010
2	Capecitabine (Xeloda)FDA Link 01/2021 - 01/2016
2	Transcription Factors (Transcription Factor)IBA 11/2017 - 10/2010
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2016 - 04/2009
2	Sirolimus (Rapamycin)FDA Link 03/2013 - 07/2011
2	temsirolimus FDA Link 03/2013 - 07/2011
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2013 - 07/2008
2	5- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA 01/2013 - 04/2012
2	Tyrosine Kinase InhibitorsIBA 07/2012 - 07/2008
2	Somatomedin Receptors (Somatomedin Receptor)IBA 07/2012 - 01/2010
2	isomaltulose (palatinose)IBA 03/2010 - 04/2007
2	Fluorouracil (Carac)FDA LinkGeneric 04/2009 - 09/2003
2	Imatinib Mesylate (Gleevec)FDA Link 01/2009 - 09/2005
2	Messenger RNA (mRNA)IBA 11/2005 - 10/2004
1	vasectrin I (VS I)IBA 01/2022
1	4-azidosalicylic acid-phosphatidylserineIBA 01/2022
1	PotassiumIBA 08/2021
1	SteroidsIBA 08/2021
1	Tumor Biomarkers (Tumor Markers)IBA 07/2021
1	Rosuvastatin Calcium (Crestor)FDA Link 01/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021
1	Pemetrexed (MTA)FDA Link 01/2020
1	RNA (Ribonucleic Acid)IBA 02/2016
1	mirdametinibIBA 07/2015
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 07/2015
1	polyglucosanIBA 09/2013
1	Fibrinogen (Factor I)FDA Link 03/2013
1	Pharmaceutical PreparationsIBA 03/2013
1	Molecular Chaperones (Chaperone, Molecular)IBA 01/2013
1	MidkineIBA 01/2013
1	Heparin (Liquaemin)FDA LinkGeneric 01/2013
1	Small Interfering RNA (siRNA)IBA 07/2012
1	Adenosine Triphosphate (ATP)IBA 07/2012
1	NVP-AEW541IBA 07/2012
1	AntibodiesIBA 07/2012
1	AntigensIBA 12/2011
1	Monatide (IMS 3015)IBA 12/2011
1	Peptides (Polypeptides)IBA 12/2011
1	PicibanilIBA 12/2011
1	VaccinesIBA 12/2011
1	Glutamine (L-Glutamine)FDA Link 02/2011
1	Androgen Receptors (Androgen Receptor)IBA 01/2011
1	Collagen Type IV (Type IV Collagen)IBA 01/2011
1	Surface-Active Agents (Surfactants)IBA 12/2010
1	CCAAT-Enhancer-Binding Protein-alphaIBA 12/2010
1	Pulmonary Surfactants (Pulmonary Surfactant)IBA 12/2010
1	Telomerase (Telomerase Reverse Transcriptase)IBA 12/2010
1	AmidesIBA 11/2010

Therapy/Procedure

16	Therapeutics 05/2015 - 01/2007
5	Esophagectomy 12/2012 - 10/2004
4	Drug Therapy (Chemotherapy) 05/2021 - 10/2004
4	Oral Administration 05/2015 - 07/2008
3	Lymph Node Excision (Lymph Node Dissection) 01/2022 - 05/2015
3	Gastrectomy 01/2022 - 10/2020
2	Adjuvant Chemotherapy 01/2016 - 05/2015
1	Colectomy 07/2021
1	Decompression 07/2021
1	Ileostomy 05/2021
1	Segmental Mastectomy (Lumpectomy) 01/2019
1	Metastasectomy 01/2019